Showing 9001-9010 of 21418 results for "".
Bridging the Gap to Improved Schizophrenia Treatment Options
https://reachmd.com/programs/neurofrontiers/bridging-the-gap-to-improved-schizophrenia-treatment-options/27072/Explore the connection between schizophrenia and substance abuse, and discover potential treatment pathways for optimal care.Women In Aesthetics: Mary Gardner, DelNova, Inc
https://reachmd.com/topics/skincare/women-in-aesthetics-mary-gardner-delnova-inc/35165/Advanced ATTR-CM Complications: A Pattern of Progressive Physiological Instability
https://reachmd.com/programs/spotlight-attr-cm/advanced-attr-cm-complications-progressive-instability/67388/Inside the IgAN Clinic: Shared Decision-Making Into Practice
https://reachmd.com/programs/cme/inside-the-igan-clinic-shared-decision-making-into-practice/26633/Learn how to apply shared decision-making principles to align treatment goals and patient priorities when managing IgA nephropathy.Decoding IgA Nephropathy: From Suspicion to Solution
https://reachmd.com/programs/cme/decoding-iga-nephropathy-from-suspicion-to-solution/26634/Examine mechanisms, diagnostics, and novel therapies in IgA nephropathy (IgAN) to inform evidence-based, personalized treatment plans.APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
https://reachmd.com/clinical-practice/cardiology/apoc3-inhibition-in-fcs-and-severe-hypertriglyceridemia/68945/Dr. Erik Stroes discusses APOC3 inhibition in familial chylomicronemia syndrome (FCS) and severe hypertriglyceridemia, focusing on its effects on triglyceride levels and acute pancreatitis risk. He also highlights new long-term data with olezarsen from the CORE-OLE study in patients with severe hypeThe FDA Expands Indication for Baloxavir Marboxil to Include Post-Exposure Influenza Prevention
https://reachmd.com/programs/the-drug-report/the-fda-expands-indication-for-baloxavir-marboxil-to-include-post-exposure-influenza-prevention/12043/Previously used for acute uncomplicated influenza, baloxavir marboxil has been approved by the FDA for post-exposure influenza prevention.The Impact of ESHRE 2017 on Japanese Fertility Practice
https://reachmd.com/programs/global-womens-health-academy/impact-eshre-2017-japanese-fertility-practice/9787/This activity includes summaries and impacts of ESHRE 2017 from thought leaders, pertaining to practicing Japanese fertility specialists.Clear Skin, Clear Path: Transforming Psoriasis Care with Durable Biologic and Oral IL-23 Innovations
https://reachmd.com/programs/cme/clear-skin-clear-path-transforming-psoriasis-care-with-durable-biologic-and-oral-il-23-innovations/49227/Join us to learn practical strategies for earlier systemic therapy initiation and why you should consider integrating oral IL-23 inhibitors into psoriasis management.Updates in Major Depressive Disorder with Insomnia
https://reachmd.com/programs/cme/updates-in-major-depressive-disorder-with-insomnia/36556/Join us to learn about the emerging data in the management of major depressive disorder with insomnia.